{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T20:01:25Z","timestamp":1791489685688,"version":"4.3.4"},"reference-count":37,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,10,17]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>The aim of this study is to analyze height after cessation of growth (final height [FH]) and its evolution over the last decades in X-linked hypophosphatemia (XLH) patients in France, as the data on natural history of FH in XLH are lacking.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Design<\/jats:title>\n                  <jats:p>We performed a retrospective observational study in a large cohort of French XLH patients with available data on FH measurements.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Materials and methods<\/jats:title>\n                  <jats:p>We divided patients into 3 groups according to their birth year: group 1 born between 1950 and 1974, group 2 born between 1975 and 2000, and group 3 born between 2001 and 2006, respectively, and compared their FHs.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>A total of 398 patients were included. Mean FHs were the following: for group 1, \u22122.31 \u00b1 1.11 standard deviation score (SDS) (n = 127), 156.3 \u00b1 9.7\u2005cm in men and 148.6 \u00b1 6.5\u2005cm in women; for group 2, \u22121.63 \u00b1 1.13 SDS (n = 193), 161.6 \u00b1 8.5\u2005cm in men and 153.1 \u00b1 7.2\u2005cm in women; and for group 3, \u22121.34 \u00b1 0.87 SDS (n = 78), 165.1 \u00b1 5.5\u2005cm in men and 154.7 \u00b1 6\u2005cm in women. We report a significant increase in mean FH SDS over 3 generations of patients, for both men and women (P &amp;lt; .001). Final height SDS in male (\u22122.08 \u00b1 1.18) was lower than in female (\u22121.70 \u00b1 1.12) (P = .002).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>The FH of XLH patients in France increased significantly over the last decades. Even though men's FHs improved more than women's, men with XLH remain shorter reflecting a more severe disease phenotype. While the results are promising, most patients with XLH remain short leaving room for improvement.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ejendo\/lvad144","type":"journal-article","created":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T18:02:31Z","timestamp":1697220151000},"page":"469-475","source":"Crossref","is-referenced-by-count":9,"title":["Adult height improved over decades in patients with X-linked hypophosphatemia: a cohort study"],"prefix":"10.1093","volume":"189","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6456-5228","authenticated-orcid":false,"given":"Emese","family":"Boros","sequence":"first","affiliation":[{"name":"Pediatric Endocrinology Unit, H\u00f4pital Universitaire de Bruxelles (HUB), H\u00f4pital Universitaire des Enfants Reine Fabiola (HUDERF), Universit\u00e9 Libre de Bruxelles , Brussels 1020 , Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9404-0975","authenticated-orcid":false,"given":"Diana-Alexandra","family":"Ertl","sequence":"additional","affiliation":[{"name":"AP-HP, Department of Endocrinology and Diabetes for Children, Department of Adolescent Medicine, Bicetre Paris-Saclay University Hospital , 78 Rue du General Leclerc , Le Kremlin-Bic\u00eatre 94270, France"},{"name":"AP-HP, Reference Center for Rare Disorders of the Calcium and Phosphate Metabolism, Filiere OSCAR and Platform of Expertise for Rare Diseases Paris-Saclay, Bicetre Paris-Saclay Hospital , 78 Rue du General Leclerc , Le Kremlin-Bic\u00eatre 94270, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jugurtha","family":"Berkenou","sequence":"additional","affiliation":[{"name":"AP-HP, Department of Endocrinology and Diabetes for Children, Department of Adolescent Medicine, Bicetre Paris-Saclay University Hospital , 78 Rue du General Leclerc , Le Kremlin-Bic\u00eatre 94270, France"},{"name":"AP-HP, Reference Center for Rare Disorders of the Calcium and Phosphate Metabolism, Filiere OSCAR and Platform of Expertise for Rare Diseases Paris-Saclay, Bicetre Paris-Saclay Hospital , 78 Rue du General Leclerc , Le Kremlin-Bic\u00eatre 94270, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christelle","family":"Audrain","sequence":"additional","affiliation":[{"name":"AP-HP, Department of Endocrinology and Diabetes for Children, Department of Adolescent Medicine, Bicetre Paris-Saclay University Hospital , 78 Rue du General Leclerc , Le Kremlin-Bic\u00eatre 94270, France"},{"name":"AP-HP, Reference Center for Rare Disorders of the Calcium and Phosphate Metabolism, Filiere OSCAR and Platform of Expertise for Rare Diseases Paris-Saclay, Bicetre Paris-Saclay Hospital , 78 Rue du General Leclerc , Le Kremlin-Bic\u00eatre 94270, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne Lise","family":"Lecoq","sequence":"additional","affiliation":[{"name":"AP-HP, Centre de Recherche Clinique Paris Saclay, H\u00f4pital Bic\u00eatre, Le Kremlin-Bic\u00eatre 94270, France"},{"name":"Assistance Publique-H\u00f4pitaux de Paris (AP-HP), H\u00f4pital de Bic\u00eatre, Service d\u2019Endocrinologie et des Maladies de la Reproduction, Centre de R\u00e9f\u00e9rence des Maladies Rares du M\u00e9tabolisme du Calcium et du Phosphate, Fili\u00e8re OSCAR , 78 rue du G\u00e9n\u00e9ral Leclerc , Le Kremlin-Bic\u00eatre 94270, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Kamenicky","sequence":"additional","affiliation":[{"name":"Assistance Publique-H\u00f4pitaux de Paris (AP-HP), H\u00f4pital de Bic\u00eatre, Service d\u2019Endocrinologie et des Maladies de la Reproduction, Centre de R\u00e9f\u00e9rence des Maladies Rares du M\u00e9tabolisme du Calcium et du Phosphate, Fili\u00e8re OSCAR , 78 rue du G\u00e9n\u00e9ral Leclerc , Le Kremlin-Bic\u00eatre 94270, France"},{"name":"Physiologie et Physiopathologie Endocriniennes, Universit\u00e9 Paris-Saclay, Inserm , Le Kremlin-Bic\u00eatre 94276 , France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karine","family":"Briot","sequence":"additional","affiliation":[{"name":"Rheumatology Department, Universit\u00e9 Paris-Cit\u00e9, Cochin Hospital , Paris 75014 , France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cyril","family":"Amouroux","sequence":"additional","affiliation":[{"name":"Service de N\u00e9phrologie et Endocrinologie P\u00e9diatriques, CHU de Montpellier, Montpellier 34090, France"},{"name":"Facult\u00e9 de M\u00e9decine, Universit\u00e9 de Montpellier , Montpellier 34090 , France"},{"name":"Centres Maladies Rares M\u00e9tabolisme du Calcium et du Phosphore et Maladies Osseuses Constitutionnelles, Fili\u00e8re de Sant\u00e9 Maladies Rares OSCAR, 34090 Montpellier, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Volha","family":"Zhukouskaya","sequence":"additional","affiliation":[{"name":"AP-HP, Department of Endocrinology, H\u00f4pital Cochin , Paris 75014 , France"},{"name":"Institut des Maladies Musculo-squelettiques, Laboratory Orofacial Pathologies, Imaging and Biotherapies URP2496 and FHU-DDS-Net, Dental School, and Plateforme d\u2019Imagerie du Vivant (PIV), Universit\u00e9 Paris Cit\u00e9 , Montrouge 92129 , France"},{"name":"Centre de R\u00e9f\u00e9rence des Maladies Rares du M\u00e9tabolisme du Calcium et du Phosphate, Plateforme d\u2019Expertise Maladies Rares Paris Saclay, Fili\u00e8re OSCAR, EndoRare and BOND ERN, H\u00f4pital de Bic\u00eatre , Le Kremlin-Bic\u00eatre 94270 , France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3562-6973","authenticated-orcid":false,"given":"Iva","family":"Gueorguieva","sequence":"additional","affiliation":[{"name":"Pediatric Endocrine Unit, CHU Lille, Universit\u00e9 Lille , Lille 59800 , France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitte","family":"Mignot","sequence":"additional","affiliation":[{"name":"Service de M\u00e9decine P\u00e9diatrique, CHRU J Minjoz , 3 Boulevard Fleming , Besan\u00e7on 25030, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Girerd","sequence":"additional","affiliation":[{"name":"AP-HP, Department of Endocrinology and Diabetes for Children, Department of Adolescent Medicine, Bicetre Paris-Saclay University Hospital , 78 Rue du General Leclerc , Le Kremlin-Bic\u00eatre 94270, France"},{"name":"AP-HP, Reference Center for Rare Disorders of the Calcium and Phosphate Metabolism, Filiere OSCAR and Platform of Expertise for Rare Diseases Paris-Saclay, Bicetre Paris-Saclay Hospital , 78 Rue du General Leclerc , Le Kremlin-Bic\u00eatre 94270, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerie","family":"Porquet Bordes","sequence":"additional","affiliation":[{"name":"Endocrine, Bone Diseases and Genetics Unit, Reference Centre for Rare Diseases of Calcium and Phosphate Metabolism, Competence Centre for Bone Diseases, ERN BOND, OSCAR Network, Children's Hospital, Toulouse University Hospital , Toulouse 31059 , France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Pierre","family":"Salles","sequence":"additional","affiliation":[{"name":"Unit\u00e9 d\u2019Endocrinologie, Maladies Osseuses, H\u00f4pital des Enfants, Centre de R\u00e9f\u00e9rence des Maladies Rares du Calcium et du Phosphate, ENR BOND, H\u00f4pital des Enfants, CHU de Toulouse , TSA 70034 , Toulouse 31059, France"},{"name":"INFINITY CENTER, INSERM CNRS UMR 1291, Universit\u00e9 de Toulouse, Paul Sabatier Toulouse III, H\u00f4pital Purpan , Toulouse 31024 , France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Edouard","sequence":"additional","affiliation":[{"name":"Endocrine, Bone Diseases and Genetics Unit, Toulouse University Hospital , Toulouse 31059 , France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u00e9gis","family":"Coutant","sequence":"additional","affiliation":[{"name":"Unit\u00e9 d\u2019 Endocrinologie Diabetologie P\u00e9diatrique and Centre des Maladies Rares de la R\u00e9ceptivit\u00e9 Hormonale, CHU-Angers , Angers 49055 , France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0578-2529","authenticated-orcid":false,"given":"Justine","family":"Bacchetta","sequence":"additional","affiliation":[{"name":"Centre de R\u00e9f\u00e9rence des Maladies R\u00e9nales Rares, Centre de R\u00e9f\u00e9rence des Maladies Rares du Calcium et du Phosphore, Fili\u00e8res Sant\u00e9 Maladies Rares OSCAR et ORKID, Fili\u00e8res Sant\u00e9 ERKNet et BOND, INSERM1033, Universit\u00e9 de Lyon , Lyon 69372 , France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3455-002X","authenticated-orcid":false,"given":"Agn\u00e8s","family":"Linglart","sequence":"additional","affiliation":[{"name":"AP-HP, Department of Endocrinology and Diabetes for Children, Department of Adolescent Medicine, Bicetre Paris-Saclay University Hospital , 78 Rue du General Leclerc , Le Kremlin-Bic\u00eatre 94270, France"},{"name":"AP-HP, Reference Center for Rare Disorders of the Calcium and Phosphate Metabolism, Filiere OSCAR and Platform of Expertise for Rare Diseases Paris-Saclay, Bicetre Paris-Saclay Hospital , 78 Rue du General Leclerc , Le Kremlin-Bic\u00eatre 94270, France"},{"name":"Physiologie et Physiopathologie Endocriniennes, Universit\u00e9 Paris-Saclay, Inserm , Le Kremlin-Bic\u00eatre 94276 , France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9246-5160","authenticated-orcid":false,"given":"Anya","family":"Rothenbuhler","sequence":"additional","affiliation":[{"name":"AP-HP, Department of Endocrinology and Diabetes for Children, Department of Adolescent Medicine, Bicetre Paris-Saclay University Hospital , 78 Rue du General Leclerc , Le Kremlin-Bic\u00eatre 94270, France"},{"name":"AP-HP, Reference Center for Rare Disorders of the Calcium and Phosphate Metabolism, Filiere OSCAR and Platform of Expertise for Rare Diseases Paris-Saclay, Bicetre Paris-Saclay Hospital , 78 Rue du General Leclerc , Le Kremlin-Bic\u00eatre 94270, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,10,13]]},"reference":[{"issue":"1","key":"2023102608070711300_lvad144-B1","doi-asserted-by":"crossref","first-page":"R13","DOI":"10.1530\/EC-13-0103","article-title":"Therapeutic management of hypophosphatemic rickets from infancy to adulthood","volume":"3","author":"Linglart","year":"2014","journal-title":"Endocr Connect"},{"issue":"6","key":"2023102608070711300_lvad144-B2","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1101\/gr.7.6.573","article-title":"Genomic organization of the human PEX gene mutated in X-linked dominant hypophosphatemic rickets","volume":"7","author":"Francis","year":"1997","journal-title":"Genome Res"},{"issue":"1","key":"2023102608070711300_lvad144-B3","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s13023-019-1014-8","article-title":"Fgf23 and its role in X-linked hypophosphatemia-related morbidity","volume":"14","author":"Beck-Nielsen","year":"2019","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"2023102608070711300_lvad144-B4","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s11154-017-9408-1","article-title":"X-linked hypophosphatemia and growth","volume":"18","author":"Fuente","year":"2017","journal-title":"Rev Endocr Metab Disord"},{"issue":"7","key":"2023102608070711300_lvad144-B5","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1210\/js.2018-00365","article-title":"The lifelong impact of X-linked hypophosphatemia: results from a burden of disease survey","volume":"3","author":"Skrinar","year":"2019","journal-title":"J Endocr Soc"},{"issue":"10","key":"2023102608070711300_lvad144-B6","doi-asserted-by":"crossref","first-page":"3243","DOI":"10.1210\/clinem\/dgaa495","article-title":"Growth curves for children with X-linked hypophosphatemia","volume":"105","author":"Mao","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"2023102608070711300_lvad144-B7","doi-asserted-by":"crossref","first-page":"101392","DOI":"10.1016\/j.ghir.2021.101392","article-title":"Impact of short stature on quality of life: a systematic literature review","volume":"57\u201358","author":"Backeljauw","year":"2021","journal-title":"Growth Horm IGF Res"},{"issue":"3","key":"2023102608070711300_lvad144-B8","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1093\/nutrit\/nuv105","article-title":"Adult height, nutrition, and population health","volume":"74","author":"Perkins","year":"2016","journal-title":"Nutr Rev"},{"key":"2023102608070711300_lvad144-B9","volume-title":"Auxologie M\u00e9thode et S\u00e9quences","author":"Semp\u00e9","year":"1979"},{"issue":"3","key":"2023102608070711300_lvad144-B10","doi-asserted-by":"crossref","first-page":"e0120806","DOI":"10.1371\/journal.pone.0120806","article-title":"Should the WHO growth charts be used in France?","volume":"10","author":"Scherdel","year":"2015","journal-title":"PLoS One"},{"issue":"8668","key":"2023102608070711300_lvad144-B11","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/S0140-6736(89)91559-6","article-title":"Hypophosphataemic rickets: final height and clinical symptoms in adults","volume":"2","author":"Stickler","year":"1989","journal-title":"Lancet"},{"issue":"26","key":"2023102608070711300_lvad144-B12","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1056\/NEJM199112263252604","article-title":"Effects of therapy in X-linked hypophosphatemic rickets","volume":"325","author":"Verge","year":"1991","journal-title":"N Engl J Med"},{"issue":"1","key":"2023102608070711300_lvad144-B13","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S0022-3476(81)80951-1","article-title":"Long-term treatment of familial hypophosphatemic rickets with oral phosphate and 1 alpha-hydroxyvitamin D3","volume":"99","author":"Rasmussen","year":"1981","journal-title":"J Pediatr"},{"issue":"2","key":"2023102608070711300_lvad144-B14","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1507\/endocrj.47.163","article-title":"Final height of Japanese patients with X-linked hypophosphatemic rickets: effect of vitamin D and phosphate therapy","volume":"47","author":"Miyamoto","year":"2000","journal-title":"Endocr J"},{"issue":"5","key":"2023102608070711300_lvad144-B15","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1007\/s10545-018-0147-6","article-title":"Outcome of adult patients with X-linked hypophosphatemia caused by PHEX gene mutations","volume":"41","author":"Chesher","year":"2018","journal-title":"J Inherit Metab Dis"},{"issue":"5","key":"2023102608070711300_lvad144-B16","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s004670050340","article-title":"X-linked hypophosphatemia: effects of treatment with recombinant human growth hormone","volume":"11","author":"Reusz","year":"1997","journal-title":"Pediatr Nephrol Berl Ger"},{"issue":"3","key":"2023102608070711300_lvad144-B17","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S0022-3476(95)70070-6","article-title":"Long-term growth hormone treatment in children with renal hypophosphatemic rickets: effects on growth, mineral metabolism, and bone density","volume":"127","author":"Saggese","year":"1995","journal-title":"J Pediatr"},{"issue":"5","key":"2023102608070711300_lvad144-B18","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1542\/peds.100.5.879","article-title":"The effect of recombinant human growth hormone in children with X-linked hypophosphatemia","volume":"100","author":"Seikaly","year":"1997","journal-title":"Pediatrics"},{"key":"2023102608070711300_lvad144-B19","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ghir.2017.08.001","article-title":"Two-year recombinant human growth hormone (rhGH) treatment is more effective in pre-pubertal compared to pubertal short children with X-linked hypophosphatemic rickets (XLHR)","volume":"36","author":"Rothenbuhler","year":"2017","journal-title":"Growth Horm IGF Res"},{"issue":"3","key":"2023102608070711300_lvad144-B20","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s00467-017-3820-3","article-title":"Effects of growth hormone treatment on adult height in severely short children with X-linked hypophosphatemic rickets","volume":"33","author":"Meyerhoff","year":"2018","journal-title":"Pediatr Nephrol Berl Ger"},{"issue":"1","key":"2023102608070711300_lvad144-B21","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1186\/s13023-022-02590-5","article-title":"Growth hormone treatment improves final height in children with X-linked hypophosphatemia","volume":"17","author":"Andr\u00e9","year":"2022","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"2023102608070711300_lvad144-B22","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1186\/s13023-022-02562-9","article-title":"Growth pattern in children with X-linked hypophosphatemia treated with burosumab and growth hormone","volume":"17","author":"Ertl","year":"2022","journal-title":"Orphanet J Rare Dis"},{"issue":"2","key":"2023102608070711300_lvad144-B23","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1067\/mpd.2001.108955","article-title":"Effect of growth hormone treatment on final height, phosphate metabolism, and bone mineral density in children with X-linked hypophosphatemic rickets","volume":"138","author":"Baroncelli","year":"2001","journal-title":"J Pediatr"},{"issue":"8","key":"2023102608070711300_lvad144-B24","doi-asserted-by":"crossref","first-page":"3591","DOI":"10.1210\/jc.2003-030036","article-title":"Early treatment improves growth and biochemical and radiographic outcome in X-linked hypophosphatemic rickets","volume":"88","author":"M\u00e4kitie","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl 1","key":"2023102608070711300_lvad144-B25","first-page":"119","article-title":"Spontaneous growth and effect of early therapy with calcitriol and phosphate in X-linked hypophosphatemic rickets","volume":"15","author":"Cagnoli","year":"2017","journal-title":"Pediatr Endocrinol Rev PER"},{"issue":"39","key":"2023102608070711300_lvad144-B26","doi-asserted-by":"crossref","first-page":"37419","DOI":"10.1074\/jbc.M304544200","article-title":"Regulation of fibroblastic growth factor 23 expression but not degradation by PHEX","volume":"278","author":"Liu","year":"2003","journal-title":"J Biol Chem"},{"issue":"21","key":"2023102608070711300_lvad144-B27","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1056\/NEJMoa1714641","article-title":"Burosumab therapy in children with X-linked hypophosphatemia","volume":"378","author":"Carpenter","year":"2018","journal-title":"N Engl J Med"},{"issue":"10189","key":"2023102608070711300_lvad144-B28","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1016\/S0140-6736(19)30654-3","article-title":"Burosumab versus conventional therapy in children with X-linked hypophosphataemia: a randomised, active-controlled, open-label, phase 3 trial","volume":"393","author":"Imel","year":"2019","journal-title":"Lancet Lond Engl"},{"issue":"3","key":"2023102608070711300_lvad144-B29","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S2213-8587(18)30338-3","article-title":"Efficacy and safety of burosumab in children aged 1-4 years with X-linked hypophosphataemia: a multicentre, open-label, phase 2 trial","volume":"7","author":"Whyte","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"4","key":"2023102608070711300_lvad144-B30","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1530\/EJE-21-0429","article-title":"Magnetic resonance imaging is a valuable tool to evaluate the therapeutic efficacy of burosumab in children with X-linked hypophosphatemia","volume":"185","author":"Zhukouskaya","year":"2021","journal-title":"Eur J Endocrinol"},{"issue":"8","key":"2023102608070711300_lvad144-B31","doi-asserted-by":"crossref","first-page":"e3241","DOI":"10.1210\/clinem\/dgac296","article-title":"Effect of burosumab compared with conventional therapy on younger vs older children with X-linked hypophosphatemia","volume":"107","author":"Ward","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"2023102608070711300_lvad144-B32","doi-asserted-by":"crossref","first-page":"e13410","DOI":"10.7554\/eLife.13410","article-title":"A century of trends in adult human height","volume":"5","author":"NCD Risk Factor Collaboration (NCD-RisC)","year":"2016","journal-title":"eLife"},{"key":"2023102608070711300_lvad144-B33","doi-asserted-by":"crossref","first-page":"106","DOI":"10.3389\/fendo.2020.00106","article-title":"People are taller in countries with better environmental conditions","volume":"11","author":"German","year":"2020","journal-title":"Front Endocrinol"},{"issue":"33","key":"2023102608070711300_lvad144-B34","doi-asserted-by":"crossref","first-page":"13232","DOI":"10.1073\/pnas.0611500104","article-title":"Height, health, and development","volume":"104","author":"Deaton","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"2023102608070711300_lvad144-B35","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1007\/s00223-010-9373-0","article-title":"Phenotype presentation of hypophosphatemic rickets in adults","volume":"87","author":"Beck-Nielsen","year":"2010","journal-title":"Calcif Tissue Int"},{"issue":"1","key":"2023102608070711300_lvad144-B36","first-page":"33","article-title":"Clinical course of hypophosphatemic rickets in 23 adults","volume":"45","author":"Berndt","year":"1996","journal-title":"Clin Nephrol"},{"issue":"8","key":"2023102608070711300_lvad144-B37","doi-asserted-by":"crossref","first-page":"e413","DOI":"10.1016\/S2589-7500(19)30149-9","article-title":"A big-data approach to producing descriptive anthropometric references: a feasibility and validation study of paediatric growth charts","volume":"1","author":"Heude","year":"2019","journal-title":"Lancet Digit Health"}],"container-title":["European Journal of Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ejendo\/advance-article-pdf\/doi\/10.1093\/ejendo\/lvad144\/52078519\/lvad144.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ejendo\/article-pdf\/189\/4\/469\/52560308\/lvad144.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ejendo\/article-pdf\/189\/4\/469\/52560308\/lvad144.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,26]],"date-time":"2023-10-26T08:07:39Z","timestamp":1698307659000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ejendo\/article\/189\/4\/469\/7311115"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,10,17]]}},"URL":"https:\/\/doi.org\/10.1093\/ejendo\/lvad144","relation":{},"ISSN":["0804-4643","1479-683X"],"issn-type":[{"value":"0804-4643","type":"print"},{"value":"1479-683X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,10]]},"published":{"date-parts":[[2023,10]]}}}